Sawyer R T, Garner R E, Hudson J A
Division of Biomedical Science, Mercer University School of Medicine, Macon, Georgia 31207.
Infect Immun. 1992 Mar;60(3):1041-6. doi: 10.1128/iai.60.3.1041-1046.1992.
The isolated perfused mouse liver model was used to study the effects of various lectins on hepatic trapping and killing of Candida albicans. After mouse livers were washed with 20 to 30 ml of perfusion buffer, 10(6) C. albicans CFU were infused into the livers. At the time of recovery, 63% +/- 2% (mean +/- standard error of the mean) of the infused C. albicans CFU were recovered from the liver and 14% +/- 1% were recovered from the effluent for a total recovery of 77% +/- 2%. This indicated that 86% +/- 9% of the original inoculum was trapped by the liver and that 23% +/- 2% was killed within the liver. When included in both preperfusion and postperfusion buffers (0.2 mg of lectin per ml), Ulex europeaus lectin (binding specificity for fucose) decreased hepatic trapping of C. albicans by 37% and eluted trapped C. albicans from the liver only when included in postperfusion buffer. By comparison, treatment of C. albicans with U. europeaus lectin before infusion had no effect on the trapping or killing of yeast cells. When Lens culinaris lectin (binding specificity for mannose) was included in the perfusion buffers, hepatic killing of C. albicans increased by 16% with no significant effect on hepatic killing when yeast cells were treated with L. culinaris lectin before infusion. Forty to 55% of the infused C. albicans were killed when concanavalin A (binding specificities for mannose and glucose), Glycine max (binding specificity for N-acetylgalactosamine), or Arachis hypogea (binding specificity for galactose) lectin was included in the perfusion buffer or when yeast cells were treated with these lectins before their infusion. When C. albicans was treated with concanavalin A at a concentration of less than 0.02 mg/ml, hepatic killing of yeast cells was not significantly increased. The data suggest that a fucose-containing receptor on the surface of either sinusoidal endothelial cells or Kupffer cells is involved in the trapping of C. albicans by the perfused mouse liver. Moreover, lectins with binding specificities for mannose, N-acetylgalactosamine, and galactose increased hepatic killing of C. albicans.
采用离体灌注小鼠肝脏模型研究了各种凝集素对白色念珠菌肝脏捕获和杀伤的影响。用20至30毫升灌注缓冲液冲洗小鼠肝脏后,将10(6)个白色念珠菌CFU注入肝脏。回收时,从肝脏中回收了63%±2%(平均值±平均标准误差)注入的白色念珠菌CFU,从流出物中回收了14%±1%,总回收率为77%±2%。这表明86%±9%的原始接种物被肝脏捕获,23%±2%在肝脏内被杀死。当欧洲荆豆凝集素(对岩藻糖具有结合特异性)同时包含在灌注前和灌注后的缓冲液中(每毫升0.2毫克凝集素)时,白色念珠菌的肝脏捕获率降低了37%,并且只有当包含在灌注后缓冲液中时才会将捕获的白色念珠菌从肝脏中洗脱出来。相比之下,在注入前用欧洲荆豆凝集素处理白色念珠菌对酵母细胞的捕获或杀伤没有影响。当在灌注缓冲液中加入菜豆凝集素(对甘露糖具有结合特异性)时,白色念珠菌的肝脏杀伤率增加了16%,而在注入前用菜豆凝集素处理酵母细胞时,对肝脏杀伤没有显著影响。当在灌注缓冲液中加入伴刀豆球蛋白A(对甘露糖和葡萄糖具有结合特异性)、大豆凝集素(对N-乙酰半乳糖胺具有结合特异性)或花生凝集素(对半乳糖具有结合特异性)凝集素,或者在注入前用这些凝集素处理酵母细胞时,40%至55%注入的白色念珠菌被杀死。当用浓度低于0.02毫克/毫升的伴刀豆球蛋白A处理白色念珠菌时,酵母细胞的肝脏杀伤率没有显著增加。数据表明,窦状内皮细胞或库普弗细胞表面含岩藻糖的受体参与了灌注小鼠肝脏对白色念珠菌的捕获。此外,对甘露糖、N-乙酰半乳糖胺和半乳糖具有结合特异性的凝集素增加了白色念珠菌的肝脏杀伤率。